Senna leaf
- Generic Name
- Senna leaf
- Drug Type
- Biotech
- Unique Ingredient Identifier
- AK7JF626KX
- Associated Conditions
- Constipation
PEG3350 Vs Senna After Urogyn Surgery
Phase 4
Not yet recruiting
- Conditions
- Obstructive Defecation SyndromePostoperative Constipation
- Interventions
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- St. Joseph's Health, New York
- Target Recruit Count
- 254
- Registration Number
- NCT06825260
- Locations
- 🇺🇸
St. Joseph's Health Hospital, Syracuse, New York, United States
RELISTOR's Effects on Opioid-Induced Constipation
Withdrawn
- Conditions
- OIC
- Interventions
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- Methodist Health System
- Registration Number
- NCT04930237
- Locations
- 🇺🇸
Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center, Dallas, Texas, United States
Bowel Preparation in Elective Pediatric Colorectal Surgery
Not Applicable
- Conditions
- Hirschsprung Disease - Pull ThroughNecrotizing EnterocolitisInflammatory Bowel DiseasesBowel ObstructionElective SurgeryColostomyMeconium Ileus
- Interventions
- Other: Nil per osOther: Clear fluids the day before surgery
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- McMaster University
- Target Recruit Count
- 81
- Registration Number
- NCT03593252
Gut Transit Effect on Enterohepatic Circulation
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2022-09-30
- Lead Sponsor
- University Hospital Plymouth NHS Trust
- Target Recruit Count
- 19
- Registration Number
- NCT03501498
- Locations
- 🇬🇧
Derriford Hospital, Plymouth, United Kingdom
Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
Phase 4
Terminated
- Conditions
- Constipation
- Interventions
- Drug: Placebo Oral TabletDrug: Polyethylene GlycolsDrug: Magnesium Citrate Oral Liquid Product
- First Posted Date
- 2016-11-30
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Tufts Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT02977286
- Locations
- 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
Adding Stewed Apricot Juice to Senna Improves the Right-Side and Overall Colon Cleansing Quality for Colonoscopy Preparation
Phase 4
Completed
- Conditions
- Colonoscopy Preparation
- Interventions
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Camlıca Erdem Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT02665624
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
Not Applicable
Completed
- Conditions
- Colorectal Cancer Screening
- Interventions
- Device: PillCam® COLON 2 procedure-CONTROLDrug: SUPREP oral sulfate solutionDrug: SUPREP oral sulfate solution with Gastrografin
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Medtronic - MITG
- Target Recruit Count
- 122
- Registration Number
- NCT02481219
- Locations
- 🇺🇸
Franklin Gastroenterology, PLLC, Franklin, Tennessee, United States
🇺🇸Indiana University Hospital, Indianapolis, Indiana, United States
🇺🇸Pinnacle Research Group, LLC, Anniston, Alabama, United States
An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
Not Applicable
Completed
- Conditions
- Autistic DisorderEncopresis
- Interventions
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Emory University
- Target Recruit Count
- 22
- Registration Number
- NCT02383758
- Locations
- 🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States
Efficacy of Linaclotide to Senna for CIC
Not Applicable
Terminated
- Conditions
- Chronic Idiopathic Constipation
- Interventions
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2019-07-02
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT02239510
- Locations
- 🇺🇸
TriHealth, Cincinnati, Ohio, United States
Evaluating the Effect of Senna in Uremic Pruritus
Not Applicable
Completed
- Conditions
- End Stage Renal DiseasePruritus
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT02008864
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath